F.D.A. Faces Upset Over Denials of New Drugs
Source: NYT > U.S. > Politics · Bias: Center Left
Summary
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.
Related Coverage
- ‘A total disappointment’: revelers face unbearable heat at Great American State Fair (Center Left — US news | The Guardian)
- Luka Doncic weighs in on new-look Lakers roster amid heavy criticism (Right — New York Post)
- Pay-to-play cycle behind GOP's corporate tax cuts exposed in new report (Far Left — Raw Story)
- Mamdani mocked by GOP for telling New Yorkers to set thermostats to 78 (Center — The Hill News)
- READ IN FULL: Zohran Mamdani’s America 250 address from George Washington’s desk at New York City Hall (Center Right — Washington Examiner)
- Mamdani Is Telling A Brazen Lie About ‘Capitalist Mismanagement’ Of New York (Far Right — The Federalist)
- WATCH LIVE: Mamdani speaks on New York’s role in America’s founding ahead of Fourth of July (Center Right — Washington Examiner)
- New York police officers are about to be worked to extremes – and Zohran Mamdani is to blame (Far Right — BizPac Review)
More Headlines From March 5, 2026
- Trump quietly asking GOP lawmakers if he should fire Kristi Noem: White House insiders (Left)
- Total scumbag move': MAGA rages as Trump faces demands to end Texas GOP civil war (Left)
- Republicans on pins and needles in a GOP stronghold (Left)
- Political strategist details challenges Trump opponents face in GOP fortress (Left)
- Trump sets off GOP shockwave by contradicting testimony Noem made under penalty of perjury (Left)








